Details about Philip Haywood

Access statistics for papers by Philip Haywood.

Last updated 2024-11-08. Update your information in the RePEc Author Service.

Short-id: pha1380

Working Papers

2024

1. Medicare Austerity Reforms and Patient Out-of-Pocket Costs: The Experience from Australian Cancer Patients
   IZA Discussion Papers, Institute of Labor Economics (IZA)

2023

2. Examining recent mortality trends: The impact of demographic change
   OECD Health Working Papers, OECD Publishing
3. Progress on implementing and using electronic health record systems: Developments in OECD countries as of 2021
   OECD Health Working Papers, OECD Publishing
4. Provider Responses to the Expansion of Public Subsidies in Healthcare: The Case of Oral Chemotherapy Treatment in Australia
   IZA Discussion Papers, Institute of Labor Economics (IZA) View citations (1)

2022

5. International comparisons of the quality and outcomes of integrated care: Findings of the OECD pilot on stroke and chronic heart failure
   OECD Health Working Papers, OECD Publishing

2002

6. Economic evaluation of the proposed surgical scheme at Auburn Hospital: Final report, CHERE Project Report No 19
   Research Reports, CHERE, University of Technology, Sydney
7. Review of Positron Emission Tomography at Royal Prince Alfred Hospital, CHERE Project Report No 18
   Research Reports, CHERE, University of Technology, Sydney

Journal Articles

2024

1. Medicare at 40: Are We Showing Our Age?
   Australian Economic Review, 2024, 57, (2), 200-205
2. Physician responses to insurance benefit restrictions: The case of ophthalmology
   Health Economics, 2024, 33, (5), 911-928
3. Specialist Palliative Care and Health Care Costs at the End of Life
   PharmacoEconomics - Open, 2024, 8, (1), 31-47
4. Use of Health Technology Assessment for the Continued Funding of Health Technologies: The Case of Immunoglobulins for the Management of Multifocal Motor Neuropathy
   Applied Health Economics and Health Policy, 2024, 22, (1), 73-84

2023

5. Estimating the willingness-to-pay to avoid the consequences of foodborne illnesses: a discrete choice experiment
   The European Journal of Health Economics, 2023, 24, (5), 831-852

2021

6. Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia
   PLOS ONE, 2021, 16, (11), 1-19

2019

7. Real-World Cost Effectiveness of Mandatory Folic Acid Fortification of Bread-Making Flour in Australia
   Applied Health Economics and Health Policy, 2019, 17, (2), 243-254

2018

8. The prevalence of persistence and related health status: An analysis of persistently high healthcare costs in the short term and medium term
   Social Science & Medicine, 2018, 211, (C), 147-156 View citations (3)

2017

9. Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study
   PLOS ONE, 2017, 12, (10), 1-12

2012

10. Chemotherapy Administration
    PharmacoEconomics, 2012, 30, (12), 1173-1186 View citations (2)
    Also in PharmacoEconomics, 2012, 30, (12), 1173-1186 (2012)